20Slash20 Inc., the innovator behind The Eye Drink, is set to be featured in coverage of the upcoming Disruptive Growth & Life Sciences Conference hosted by Moody Capital Solutions Inc. The conference, scheduled for 2026, will showcase companies at the forefront of innovation in the life sciences and disruptive growth sectors.
The Eye Drink is marketed as the world’s first ready-to-drink functional beverage specifically formulated to address ocular issues arising from prolonged screen use. With an increasing number of individuals spending hours daily in front of computers and smartphones, the product aims to mitigate screen-induced dry eyes and potential macular damage. The formulation is based on nutrients supported by the AREDS 2 studies, a landmark clinical trial on age-related eye disease, and includes vegan-friendly, triglyceride-formed Omega-3 to support visual performance and ocular comfort.
20Slash20 is commercializing The Eye Drink through a multi-channel approach, including direct-to-consumer sales, professional medical affiliate networks, and natural product retail stores. This strategy positions the company to modernize preventive eyecare, transforming clinical science into a simple, enjoyable daily habit. The company’s website provides further details at theeyedrink.com.
The conference, organized by Moody Capital Solutions, an independent investment bank with over 40 years of experience in capital raising, M&A, and advisory services, is known for bringing together innovative companies and investors. The event will provide a platform for 20Slash20 to present its value proposition to potential partners and investors. Registration for the conference is available at https://moodycapital.com/conference/.
IBN, a multifaceted financial news and publishing company, will provide comprehensive coverage of the conference, including summaries of participating companies. This coverage is part of IBN’s decade-long commitment to offering real-time updates on global events and conferences. Through its syndicated articles and social media, IBN aims to maximize the visibility of the event and its participants. For insights into IBN’s approach, visit IBN’s conference coverage.
The inclusion of 20Slash20 in this conference highlights the growing recognition of preventive health solutions in the beverage sector. As digital device usage continues to rise, products like The Eye Drink could become essential for maintaining ocular health in a screen-centric world. This announcement not only underscores the company’s innovative approach but also signals a broader trend toward functional beverages that address specific health concerns.
For more information about 20Slash20 and its product, interested parties are encouraged to visit the company’s official website. Details about Moody Capital Solutions can be found at www.moodycapital.com.
